Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …

Introduction: There are three government-funded population-based screening programs in
Australia–the national breast cancer screening program (BreastScreen Australia), the …

Background Lung cancer screening with low-dose computed tomography (LDCT) reduces
lung cancer mortality. The aim of this study was to evaluate the cost-effectiveness of lung …

Background Chest low-dose computed tomography (LDCT) is a promising technology for
population-based screening because it is non-invasive, relatively inexpensive, associated …

Objectives The aim was to develop and validate a statistical model which uses past trends
for lung cancer mortality and historical and current data on tobacco consumption to project …

Abstract Background Never smokers in Asia have a higher incidence of lung cancer than in
Europe and North America. We aimed to assess the cost-effectiveness of lung cancer …

Objective There are large inequities in the lung cancer burden for the Indigenous Māori
population of New Zealand. We model the potential lifetime health gains, equity impacts and …

Lung cancer screening with low-dose computed tomography (LDCT) in high-risk
populations has been shown in randomised controlled trials to lead to early diagnosis and …

Background Of all cancer types, healthcare for lung cancer is the third most costly in
Australia, but there is little detailed information about these costs. Our aim was to provide …

Objective To evaluate the cost-effectiveness of the implementation of national lung cancer
(LC) screening programme (SP) in a high-risk population from the perspective of the …